WO2007098446A3 - Method for minimizing variation in dosage forms - Google Patents
Method for minimizing variation in dosage forms Download PDFInfo
- Publication number
- WO2007098446A3 WO2007098446A3 PCT/US2007/062436 US2007062436W WO2007098446A3 WO 2007098446 A3 WO2007098446 A3 WO 2007098446A3 US 2007062436 W US2007062436 W US 2007062436W WO 2007098446 A3 WO2007098446 A3 WO 2007098446A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- dosage forms
- minimizing variation
- variation
- tablet
- minimizing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Described are dosage forms and methods of manufacture of dosage forms containing one or more active ingredients, principally pharmaceuticals, which have, inter alia, less tablet-to-tablet variation,
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US77550306P | 2006-02-21 | 2006-02-21 | |
US60/775,503 | 2006-02-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007098446A2 WO2007098446A2 (en) | 2007-08-30 |
WO2007098446A3 true WO2007098446A3 (en) | 2007-12-13 |
Family
ID=38438088
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/062436 WO2007098446A2 (en) | 2006-02-21 | 2007-02-20 | Method for minimizing variation in dosage forms |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2007098446A2 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030185885A1 (en) * | 2001-08-10 | 2003-10-02 | Franz G. Andrew | Non-granulated levothyroxine pharmaceutical compositions |
US20040048931A1 (en) * | 2002-07-12 | 2004-03-11 | Craig Heacock | Modafinil pharmaceutical compositions |
US20050181042A1 (en) * | 2002-02-15 | 2005-08-18 | Bengt Herslof | Composition for oral or rectal administration |
WO2005112900A1 (en) * | 2004-05-21 | 2005-12-01 | Accu-Break Technologies, Inc. | Pharmaceutical tablets comprising two or more unitary segments |
-
2007
- 2007-02-20 WO PCT/US2007/062436 patent/WO2007098446A2/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030185885A1 (en) * | 2001-08-10 | 2003-10-02 | Franz G. Andrew | Non-granulated levothyroxine pharmaceutical compositions |
US20050181042A1 (en) * | 2002-02-15 | 2005-08-18 | Bengt Herslof | Composition for oral or rectal administration |
US20040048931A1 (en) * | 2002-07-12 | 2004-03-11 | Craig Heacock | Modafinil pharmaceutical compositions |
WO2005112900A1 (en) * | 2004-05-21 | 2005-12-01 | Accu-Break Technologies, Inc. | Pharmaceutical tablets comprising two or more unitary segments |
Also Published As
Publication number | Publication date |
---|---|
WO2007098446A2 (en) | 2007-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL190646A (en) | Multi-functional ionic liquid compositions comprising active pharmaceutical, biological, nutritional and energetic ingredients and method for producing the same | |
WO2007064857A3 (en) | Amphoteric liposome formulation | |
ZA200705750B (en) | Compositions and methods for stabilizing active pharmaceutical ingredients | |
GB0412974D0 (en) | Method of applying active ingredients | |
SG150075A1 (en) | Particles for delivery of active ingredients, process of making and compositions thereof | |
WO2007064872A3 (en) | Urea compounds useful in the treatment of cancer | |
WO2009101503A3 (en) | Use of natural active substances in cosmetic or therapeutic compositions | |
WO2007064945A3 (en) | Cancer therapies and pharmaceutical compositions used therein | |
WO2005117557A3 (en) | Expression system | |
IL190951A0 (en) | Method of acting upon organism by targeted delivery of biologicaly active substances into mitochondria, pharmaceutical composition for carrying out said method, and compound used for the purpose | |
WO2006119510A3 (en) | Isoforms of receptor for advanced glycation end products (rage) and methods of identifying and using same | |
WO2007115289A3 (en) | Combinations comprising bcr-abl/c-kit/pdgf-r tk inhibitors for treating cancer | |
PL2377396T3 (en) | Resin composition containing release-controlled agricultural chemical, production method thereof, and agricultural chemical formulation | |
WO2006113568A3 (en) | Controlled delivery dosage form of tramadol and gabapentin | |
WO2007056625A3 (en) | Thienopyridine b-raf kinase inhibitors | |
WO2007036802A3 (en) | Sublingual dosage form comrising vitamin d analogue, in particular calcitriol | |
ZA200801896B (en) | Slow-release composition, method for the preparation thereof, and use of the same | |
WO2008019782A3 (en) | Dispersions of nanoureas containing active ingredients | |
WO2006021401A3 (en) | Bicylononene derivatives | |
IL185970A0 (en) | Composition of spirulinas rich in active ingredients, method for obtaining it and its use | |
WO2007103468A3 (en) | Use of vx-702 for treating rheumatoid arthritis | |
WO2008092219A3 (en) | Pharmaceutical composition comprising tramadol and ketoprofen | |
WO2007098924A3 (en) | Composition comprising an agent for stabilizing active substances in drinking water, effervescent mixture, method for the production thereof, and use thereof | |
GB0518579D0 (en) | Controlled delivery creatine formulations and method of using the same | |
WO2006021399A3 (en) | Azabicyclononene derivatives as renin inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07757222 Country of ref document: EP Kind code of ref document: A2 |